Biotech

All Articles

Galapagos stops CAR-T tissue treatment litigation over Parkinsonism situation

.Galapagos has actually stopped briefly registration in a trial of a BCMA-directed CAR-T tissue ther...

James Wilson leaving behind Penn to release pair of brand new biotechs

.After much more than 30 years, gene treatment pioneer James Wilson M.D., Ph.D., is leaving behind t...

3 biotechs attempt to defeat the summertime heat energy through dropping staff

.As biotechs seek to transform a fresh page in August, at the very least three business have actuall...

venBio lifts $528M for fifth life sciences VC fund

.Veteran equity capital agency venBio has lifted yet another half a billion bucks to purchase biotec...

Otsuka spends $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Drug has actually picked up Boston-based Jnana Therapies for $800 million so the Eastern bio...

FibroGen gives up 75% people personnel as possession fails 2 more tests

.FibroGen is drastically restructuring its own service, giving up 75% of its own united state team a...

Tracon wane full weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually chosen to unwind procedures full weeks after an injectable immu...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M loss on neglected epilepsy drug, proclaims FDA run

.Our company presently know that Takeda is actually hoping to locate a road to the FDA for epilepsy ...

VBI Injections declare insolvency, seeks possession sale

.Immunology biotech VBI Vaccinations is drifting precariously near the climax, along with strategies...